Page last updated: 2024-08-26

peptide elongation factor 2 and Acute Liver Injury, Drug-Induced

peptide elongation factor 2 has been researched along with Acute Liver Injury, Drug-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cortés, JR; Davis, RJ; González-Rodríguez, Á; González-Terán, B; Manieri, E; Martín, P; Matesanz, N; Rodríguez, ME; Sabio, G; Valverde, Á; Valverde, ÁM; Verdugo, Á	1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and Acute Liver Injury, Drug-Induced

Article	Year
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis. The Journal of clinical investigation, 2013, Volume: 123, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Humans; Lipopolysaccharides; Macrophages; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 12; Mitogen-Activated Protein Kinase 13; Peptide Chain Elongation, Translational; Peptide Elongation Factor 2; Tumor Necrosis Factor-alpha	2013

Article

Year

Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis.

The Journal of clinical investigation, 2013, Volume: 123, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Humans; Lipopolysaccharides; Macrophages; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 12; Mitogen-Activated Protein Kinase 13; Peptide Chain Elongation, Translational; Peptide Elongation Factor 2; Tumor Necrosis Factor-alpha

2013